Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

A legfontosabb adatok

Ki végzi
University of California, San Francisco
Hol
San Francisco (Egyesült Államok)Mind a 2 helyszín megnézése
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
180 fő, tervezett
Kezdés
2022. febr. 1.
Várható befejezés
2028. febr. 27.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use
  • Usual Care (UC)
A regiszteradat frissítve
2026. október 16.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Men and women age ≥ 18 years
  • Diagnosis of chronic liver disease (CLD)
  • Unhealthy alcohol use, defined as more than moderate amount of alcohol use within the prior 30 days by National Institute on Alcohol Abuse and Alcoholism (NIAAA) criteria defined as on average more than 1 drink/day (7 drinks per week) for women and more than 2 drinks per day (14 drinks per week) for men, or on average at least one heavy drinking day (4+ drinks in a day for women and 5+ for men) per week in the prior 30 days. A standard drink is ~14 g of alcohol
  • Ability to access a telephone or a digital device (i.e., computer, tablet or smart phone)

Ki nem vehet részt

  • Severe medical or psychiatric conditions or evidence of acute alcohol intoxication preventing participation in the study
  • Are currently enrolled in formal treatment for unhealthy alcohol use, excluding self or mutual-help groups (e.g., Alcoholics Anonymous)
  • Women who are pregnant or breastfeeding or unwilling to use birth control
  • Language preference other than English, Spanish or Chinese
  • Unwilling or unable to provide informed consent

Helyszínek itt: Egyesült Államok

  • University of California San FranciscoSan Francisco, Egyesült Államok
  • Zuckerberg San Francisco General HospitalSan Francisco, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The study consists of a randomized controlled trial evaluating the efficacy and feasibility of a stepped alcohol treatment using telemedicine on unhealthy alcohol use in patients with chronic liver disease receiving care in hepatology practices at three sites. Patients who meet eligibility criteria will be randomized to one of two study arms: 1) Stepped Alcohol Treatment (SAT) or, 2) Usual Care (UC). Participants will be randomized separately by site. SAT includes 3 sessions of motivational interviewing followed by referral to addiction medicine for patients who do not reduce unhealthy drinking. Trial outcome measures will be complete at 6 and 12 months following baseline enrollment.

A vizsgálat 2 csoportja

  • Stepped alcohol intervention (SAT) to reduce unhealthy alcohol useA vizsgált kezelés

    For participants randomized to SAT, consistent with stepped care, treatment will begin with lower intensity services that are stepped up, if necessary, at a predefined time point. Step 1 consists of three motivational interviewing (MI)sessions delivered every 2 weeks. At the 3-month assessment, those with non-response to MI, defined as continued unhealthy alcohol use in the prior 14 days, will be referred to on site physician managed addiction specialty services (Step 2) for higher intensity services.

  • Usual Care (UC)Már használt kezelés, összehasonlításként

    UC participants will receive their usual services in hepatology. They will also be given publicly available patient education materials regarding risk associated with unhealthy drinking (mail/email or in-person if desired) and will be asked to follow up with their physician should they have questions about information provided in the handouts. UC participants' hepatology provider will be notified if AUDIT-C scores are greater than 3 at baseline. All UC participants will have access to alcohol and other substance use treatment available to patients at their respective sites.

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Impact of the Coronavirus 2019 (COVID-19) Pandemic on Patient Outcomes, Telehealth Care Delivery, and Treatment for Unhealthy Alcohol Use in Vulnerable Patients With Advanced Liver Disease Across Two Healthcare Systems
A regiszteradat frissítve
2026. október 16.